GSK plc
GSK
$37.56
$0.411.10%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.70% | -8.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.70% | -8.94% | |||
| Cost of Revenue | 19.02% | -25.42% | |||
| Gross Profit | 10.52% | -1.44% | |||
| SG&A Expenses | 7.76% | -22.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -63.81% | -247.52% | |||
| Total Operating Expenses | 12.49% | -28.15% | |||
| Operating Income | 13.17% | 128.26% | |||
| Income Before Tax | -5.06% | 268.23% | |||
| Income Tax Expenses | -23.93% | 432.97% | |||
| Earnings from Continuing Operations | -1.48% | 247.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -45.48% | -67.30% | |||
| Net Income | -5.76% | 285.78% | |||
| EBIT | 13.17% | 128.26% | |||
| EBITDA | 22.66% | 101.77% | |||
| EPS Basic | -5.18% | 285.14% | |||
| Normalized Basic EPS | 8.46% | 169.86% | |||
| EPS Diluted | -5.27% | 284.32% | |||
| Normalized Diluted EPS | 8.48% | 170.89% | |||
| Average Basic Shares Outstanding | -0.61% | 0.17% | |||
| Average Diluted Shares Outstanding | -0.65% | -0.19% | |||
| Dividend Per Share | 6.05% | -1.66% | |||
| Payout Ratio | 0.21% | -0.75% | |||